MannKind Corp (MNKD) insider filing shows CEO option exercises, share sales
Rhea-AI Filing Summary
MannKind Corp Chief Executive Officer and director Michael Castagna reported stock option exercises and related share sales in recent insider transactions. On 12/12/2025 he exercised 20,806 employee stock options at $4.55 per share and sold 20,806 shares of common stock at $6, leaving him with 2,504,792 common shares held directly. On 12/16/2025 he exercised a further 21,310 options at $4.55 and sold 21,310 common shares at $6, again ending with 2,504,792 directly held shares. Following these trades, he beneficially owns 15,804 employee stock options with a $4.55 exercise price expiring on 05/19/2026. The transactions were carried out under a Rule 10b5-1 trading plan established on August 8, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 21,310 | $0.00 | -- |
| Exercise | Common Stock, $0.01 Par Value | 21,310 | $4.55 | $97K |
| Sale | Common Stock, $0.01 Par Value | 21,310 | $6.00 | $128K |
| Exercise | Employee Stock Option (Right to Buy) | 7,920 | $0.00 | -- |
| Exercise | Employee Stock Option (Right to Buy) | 12,886 | $0.00 | -- |
| Exercise | Common Stock, $0.01 Par Value | 20,806 | $4.55 | $95K |
| Sale | Common Stock, $0.01 Par Value | 20,806 | $6.00 | $125K |
Footnotes (1)
- [object Object]
FAQ
What insider transactions did MannKind Corp (MNKD) report for December 2025?
MannKind Corp reported that CEO and director Michael Castagna exercised employee stock options and sold common shares on 12/12/2025 and 12/16/2025, with each option exercise matched by a sale of the same number of shares.
What stock options remain outstanding for MannKind Corp (MNKD)'s CEO after these transactions?
Following the reported transactions, Michael Castagna beneficially owns 15,804 employee stock options with an exercise price of $4.55 per share that expire on 05/19/2026.
Were the MannKind Corp (MNKD) insider trades executed under a Rule 10b5-1 plan?
Yes. The filing states that the transactions occurred pursuant to a Rule 10b5-1 plan that was established on August 8, 2025.
Is Michael Castagna both a director and an officer of MannKind Corp (MNKD)?
Yes. The report identifies Michael Castagna as a Director and an Officer, serving as MannKind Corp’s Chief Executive Officer.
What types of securities are involved in the MannKind Corp (MNKD) insider filing?
The transactions involve common stock, $0.01 par value, and employee stock options (right to buy) with a $4.55 exercise price expiring on 05/19/2026.